NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/05/2024
Back to search
Official data from USPTO
ALPHINA THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
11/05/2024
Trademark type
Combined
Nice classes
42
Filing date
01/11/2023
Registration date
11/05/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/05/2024
Last transaction
11/05/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/17/2023
First use in commerce
03/17/2023
Drawing code
3
Owner type
03
Owner location
New Haven, CT
Examiner
PURATH,ANICKA S
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "ALPHINA THERAPEUTICS" featured underneath an incomplete triangle design comprised of fifteen shaded ovals.
Holders and representatives
Holders
Alphina Therapeutics, Inc.
Alphina Therapeutics, Inc.
Representatives
Glenn M. Cunningham SHIPMAN & GOODWIN LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Medical and scientific research in the field of cancer treatment; Pharmaceutical research and development; Research and development in the field of cancer treatment
Publications
History of USPTO decisions and trademark events.
37 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/05/2024
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
10/10/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/10/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/10/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/10/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/10/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/10/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/30/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/30/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/23/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/23/2024
ALIE
ASSIGNED TO LIE
09/23/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/16/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/01/2024
GNRT
NON-FINAL ACTION E-MAILED
03/01/2024
CNRT
SU - NON-FINAL ACTION - WRITTEN
03/01/2024
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
02/29/2024
ISSR
WITHDRAWN FROM ISSUE - SENIOR ATTORNEY REQUEST
02/29/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/29/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/24/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/24/2024
IUAF
USE AMENDMENT FILED
02/01/2024
EISU
TEAS STATEMENT OF USE RECEIVED
02/01/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/02/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/07/2023
PUBO
PUBLISHED FOR OPPOSITION
11/07/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/18/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/05/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
10/05/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/05/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
10/05/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/05/2023
DOCK
ASSIGNED TO EXAMINER
10/05/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
02/02/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/01/2023
NWAP
NEW APPLICATION ENTERED
01/14/2023
Continuous trademark protection
Get notified about every new filing that threatens ALPHINA THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.